Clinical Trials in Cleveland

Showing 2801-2820 of 9,497 trials

[Study Evaluating the Efficacy and Safety of a Digital Therapeutic as an Adjunct to TAU in Postpartum Depression]

NCT05551195

This study evaluates the efficacy of two digital therapeutics, WB001 and ED001, on depressive symptoms among women diagnosed with postpartum depression.

Postpartum Depression

Woebot Health7 participantsStarted Nov 2022

Lafayette, California, United States • Santa Ana, California, United States • DeLand, Florida, United States +5 more locations

COMPLETEDPhase 4< 1 mile

Transition From Basal/Bolus to Once-weekly Subcutaneous Semaglutide and Basal Insulin in Patients With T2D

NCT04538352

This study is designed to determine whether therapy with once-weekly sc semaglutide in combination with once-daily insulin degludec will be capable of maintaining (or improving) glycemic control, when substituted for multiple daily injections of insulin (MDI), in patients with T2D with adequate glycemic control (≤ 7.5%) on MDI-based regimens (≤ 80 units of insulin per day), vs. further titration of insulin therapy in those continuing MDI. Weight loss, hypoglycemic episodes, and improvement in diabetes-treatment satisfaction will also be assessed between the two groups.

Type 2 Diabetes

The Cleveland Clinic60 participantsStarted Jan 2021

Cleveland, Ohio, United States

COMPLETEDNA< 1 mile

Safety and Effectiveness of the MiniMed™ 780G System With DS5 CGM

NCT05714059

The purpose of this study is to confirm the safety and effectiveness of the MiniMed 780G insulin pump used in combination with the DS5 CGM in type 1 diabetes adult and pediatric subjects in a home setting.

Type 1 Diabetes

Medtronic Diabetes250 participantsStarted Feb 2023

Little Rock, Arkansas, United States • Palo Alto, California, United States • San Francisco, California, United States +20 more locations

[Study Evaluating the Efficacy and Safety of a Digital Therapeutic as an Adjunct to TAU in Postpartum Depression]

Transition From Basal/Bolus to Once-weekly Subcutaneous Semaglutide and Basal Insulin in Patients With T2D

Safety and Effectiveness of the MiniMed™ 780G System With DS5 CGM

Find Trials by Condition in Cleveland

NovoTTF-100A With Bevacizumab (Avastin) in Patients With Recurrent Glioblastoma

Using Calcium Hydroxylapatite To Treat Gum Recession and Tooth Hypersensitivity

Study to Determine the Efficacy and Safety of Romosozumab in the Treatment of Postmenopausal Women With Osteoporosis

A Phase 3 Randomized, Placebo-controlled Trial of Carboplatin and Paclitaxel With or Without Veliparib (ABT-888) in HER2-negative Metastatic or Locally Advanced Unresectable BRCA-associated Breast Cancer

Persona Partial Knee Clinical Outcomes Study

Cognitive Behavioral Therapy and Real-Time Pain Management Intervention for Sickle Cell Via Mobile Applications

An Investigational Immunotherapy Study of BMS-986301 Alone or in Combination With Nivolumab, and Ipilimumab in Participants With Advanced Solid Cancers

Trial to Assess Safety and Efficacy of MOR202 in Anti-PLA2R + Membranous Nephropathy (aMN)

FUnctional diagnoSIs of corONary Stenosis (FUSION)

BioProtect Balloon Implant™ Balloon System Pivotal Study BP-007

P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC)

Quaratusugene Ozeplasmid (Reqorsa) in Combination With Pembrolizumab in Previously Treated Non-Small Lung Cancer

A Phase 1b Study of Imvotamab in Moderate to Severe Rheumatoid Arthritis

Communication During Hospitalization About Resuscitation Trial

A Study to Test Whether Spesolimab Helps People With Crohn's Disease Who Have Symptoms of Bowel Obstruction

Living WELL: A Web-Based Program for Ovarian Cancer Survivors

Long-term Follow-up of Participants With Cerebral Adrenoleukodystrophy Who Were Treated With Lenti-D Drug Product